Skip to main content
Premium Trial:

Request an Annual Quote

Kreatech Biotechnology, EcoArray

Premium
Kreatech Biotechnology recently launched Universal Linkage System amplification and labeling kits for specific use on CombiMatrix microarrays for all of its current aRNA labeling kits and RNA ampULSe amplification and labeling kits.
 
Available kits include two-color formats with Cy3 and Cy5, one-color formats with either Cy3 or Cy5, and kits with biotin ULS with the option of streptavidin phycoerythrin detection reagent, the company said.
 
Kreatech has also launched its new PlatinumLink Protein labeling kits, which can be used to label purified proteins for downstream applications.
The kits offer the company’s ULS-labeling molecule bound to Biotin, DNP, Fluorescein or Rhodamine for direct labeling of proteins.
 

 
EcoArray last week launched its Fathead Minnow 22K Array for use in research and environmental toxicology.
 

The FHM22K chip is manufactured by Agilent Technologies and was developed through collaboration with the US Food and Drug Administration that produced EcoArray's first fathead minnow microarray in 2005.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.